Skip to main content
Log in

Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Canadian Consensus guidelines regarding appropriate use of nonsteroidal anti-inflammatory drugs (NSAID) were recently published. This study was done to evaluate the application of these guidelines on NSAID practice patterns in frail elderly patients referred to a specialist Geriatric Assessment Clinic. A retrospective chart review was undertaken of referrals who were currently prescribed NSAIDs. Data were captured on age, sex, weight, diagnoses, medications and dosages, indication for NSAID treatment, lying BP (as assessed in the clinic) and recent serum creatinine result. Creatinine clearance was subsequently calculated use the Cockcroft–Gault equation. Complete data were available on 107 patients (68% women, average age 80.6 years). Thirty percent were on a traditional NSAID, the remainder were on a Coxib. Concomitant aspirin was prescribed in 37%. Cytoprotection was being used in 38% and did not increase appreciably in patients with additional risk factors for GI toxicity, i.e., concomitant aspirin usage(35%), and history of GI toxicity (48%). Sixty-seven were taking anti-hypertensive medications, although more than two thirds of these patients were uncontrolled. Newly diagnosed hypertension was present in 19.6%. Calculated creatinine clearance revealed moderate to severe renal impairment in 79% of subjects, although serum creatinine was only elevated in 18%. In total, 70% of subjects were found to have relative or absolute risk factors for NSAID therapy. Given the high prevalence of potential contraindications to anti-inflammatory drug usage in this study, we advocate the dissemination and application of these guidelines in geriatric patients in an attempt to reduce potential morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tannenbaum H, Bombardier C, Davis P, Russell AS (2006) Third Canadian Consensus Conference Group. An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33(1):140–157

    PubMed  Google Scholar 

  2. Tannenbaum H, Davis P, Russell AS et al (1996) An evidence based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus participants. CMAJ 155:77–88

    PubMed  CAS  Google Scholar 

  3. Tannenbaum H, Peloso PMJ, Russell AS, Marlow B (2000) An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 7(Suppl A):4A–16A

    PubMed  Google Scholar 

  4. Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid Arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255

    Article  PubMed  CAS  Google Scholar 

  5. Whelton A, Schulman G, Wallemark C et al (2000) Effect of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 169:1465–1470

    Article  Google Scholar 

  6. Sonomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140–145

    Article  CAS  Google Scholar 

  7. Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Non-steroidal and anti-inflammatory drugs and risk of serious coronary heart disease: an observational study. Lancet 359:118–123

    Article  PubMed  CAS  Google Scholar 

  8. Visser LE, Graatsma HH, Tricker BHC (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183–188

    Article  PubMed  Google Scholar 

  9. Abraham NS, El-Serag HB, Johnson ML (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol 129:1171–1178

    Article  Google Scholar 

  10. Van Leen MWF, Van Der Eijk I, Schols JMGA (2007) Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 36:414–418

    Article  PubMed  Google Scholar 

  11. Catella-Lawson F, Reilly MP, Kapoor SC et al (200) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817

    Article  Google Scholar 

  12. Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22

    Article  PubMed  CAS  Google Scholar 

  13. Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40

    Article  PubMed  CAS  Google Scholar 

  14. Davis P, Juby A (2007) Osteoarthritis. Therapeutic choices, 5th edn., Chapter 71. Canadian Pharmacists Association, Canada, pp 939–952

    Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela G. Juby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juby, A.G., Davis, P. Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly. Clin Rheumatol 27, 1191–1194 (2008). https://doi.org/10.1007/s10067-008-0952-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-008-0952-7

Keywords

Navigation